Fifth Third Bancorp’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Sell
67,660
-2,963
-4% -$107K ﹤0.01% 1210
2026
Q1
$2.5M Buy
70,623
+58,801
+497% +$2.39M ﹤0.01% 1104
2025
Q4
$480K Sell
11,822
-1,577
-12% -$68.6K ﹤0.01% 782
2025
Q3
$630K Sell
13,399
-882
-6% -$45.7K ﹤0.01% 735
2025
Q2
$744K Sell
14,281
-534
-4% -$29.3K ﹤0.01% 665
2025
Q1
$895K Sell
14,815
-2,881
-16% -$186K ﹤0.01% 607
2024
Q4
$1.21M Sell
17,696
-7,487
-30% -$522K ﹤0.01% 551
2024
Q3
$1.81M Sell
25,183
-980
-4% -$69.1K 0.01% 488
2024
Q2
$1.81M Buy
26,163
+8,112
+45% +$592K 0.01% 477
2024
Q1
$1.45M Buy
18,051
+672
+4% +$59.9K 0.01% 523
2023
Q4
$1.9M Buy
17,379
+987
+6% +$102K 0.01% 457
2023
Q3
$1.65M Sell
16,392
-124
-0.8% -$14.2K 0.01% 478
2023
Q2
$2.24M Sell
16,516
-3,044
-16% -$372K 0.01% 434
2023
Q1
$2.03M Buy
19,560
+599
+3% +$57.9K 0.01% 443
2022
Q4
$1.68M Buy
18,961
+5,207
+38% +$432K 0.01% 470
2022
Q3
$1.1M Buy
13,754
+13,513
+5,607% +$1.27M 0.01% 537
2022
Q2
$23K Sell
241
-11
-4% -$1.32K ﹤0.01% 1673
2022
Q1
$37K Hold
252
﹤0.01% 1569
2021
Q4
$36K Buy
252
+75
+42% +$10.6K ﹤0.01% 1651
2021
Q3
$23K Buy
177
+37
+26% +$4.84K ﹤0.01% 1739
2021
Q2
$19K Hold
140
﹤0.01% 1802
2021
Q1
$18K Buy
140
+60
+75% +$7.22K ﹤0.01% 1809
2020
Q4
$9K Buy
80
+65
+433% +$6.15K ﹤0.01% 1953
2020
Q3
$1K Buy
+15
New +$1.22K ﹤0.01% 2132
2020
Q1
Sell
-3,059
Closed -$342K 2142
2019
Q4
$342K Sell
3,059
-536
-15% -$57.1K ﹤0.01% 774
2019
Q3
$346K Sell
3,595
-721
-17% -$67.7K ﹤0.01% 748
2019
Q2
$369K Buy
4,316
+4,188
+3,272% +$344K ﹤0.01% 726
2019
Q1
$11K Hold
128
﹤0.01% 1750
2018
Q4
$8K Hold
128
﹤0.01% 1829
2018
Q3
$10K Hold
128
﹤0.01% 1824
2018
Q2
$9K Hold
128
﹤0.01% 1912
2018
Q1
$8K Hold
128
﹤0.01% 1943
2017
Q4
$7K Hold
128
﹤0.01% 1912
2017
Q3
$7K Hold
128
﹤0.01% 1856
2017
Q2
$7K Hold
128
﹤0.01% 1807
2017
Q1
$6K Buy
+128
New +$5.51K ﹤0.01% 1809
2016
Q1
Sell
-72
Closed -$3K 2370
2015
Q4
$3K Buy
72
+1
+1% +$43 ﹤0.01% 2327
2015
Q3
$3K Buy
71
+21
+42% +$1.15K ﹤0.01% 2463
2015
Q2
$3K Buy
50
+1
+2% +$54 ﹤0.01% 2428
2015
Q1
$2K Buy
+49
New +$2.4K ﹤0.01% 2454
2014
Q4
Sell
-550
Closed -$20K 2380
2014
Q3
$20K Hold
550
﹤0.01% 1765
2014
Q2
$24K Hold
550
﹤0.01% 1741
2014
Q1
$24K Hold
550
﹤0.01% 1714
2013
Q4
$23K Hold
550
﹤0.01% 1614
2013
Q3
$19K Hold
550
﹤0.01% 1678
2013
Q2
$17K Buy
+550
New +$17.8K ﹤0.01% 1638

Other funds holding CNMD

Fifth Third Bancorp's CNMD Position: Q2 2026 in Review

Fifth Third Bancorp reduced its CONMED (CNMD) stake by 4.2% in Q2 2026, selling an estimated $107K and leaving 67,660 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1210.

Fifth Third Bancorp first reported a position in CNMD in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.5M in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Fifth Third Bancorp held 67,660 shares of CONMED worth $2.21M as of Q2 2026.
  • Fifth Third Bancorp sold 2,963 CONMED shares in Q2 2026, an estimated $107K.
  • CONMED made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1210 holding.
  • Fifth Third Bancorp first reported a position in CONMED in Q2 2013 and has held it in 46 quarters since.
  • Fifth Third Bancorp's CONMED position peaked at $2.5M in Q1 2026.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.